Malaysia · Delayed Price · Currency is MYR TMC Life Sciences Berhad Statistics
Total Valuation
KLSE:TMCLIFE has a market cap or net worth of MYR 775.14 million. The enterprise value is 805.29 million.
| Market Cap | 775.14M |
| Enterprise Value | 805.29M |
Important Dates
The next estimated earnings date is Friday, September 4, 2026.
| Earnings Date | Sep 4, 2026 |
| Ex-Dividend Date | Dec 8, 2026 |
Share Statistics
KLSE:TMCLIFE has 1.74 billion shares outstanding.
| Current Share Class | 1.74B |
| Shares Outstanding | 1.74B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 12.51% |
| Owned by Institutions (%) | 0.65% |
| Float | 296.88M |
Valuation Ratios
The trailing PE ratio is 44.60.
| PE Ratio | 44.60 |
| Forward PE | n/a |
| PS Ratio | 1.97 |
| PB Ratio | 0.89 |
| P/TBV Ratio | 1.15 |
| P/FCF Ratio | 17.63 |
| P/OCF Ratio | 13.44 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.16, with an EV/FCF ratio of 18.32.
| EV / Earnings | 46.33 |
| EV / Sales | 2.05 |
| EV / EBITDA | 13.16 |
| EV / EBIT | 26.53 |
| EV / FCF | 18.32 |
Financial Position
The company has a current ratio of 1.69, with a Debt / Equity ratio of 0.17.
| Current Ratio | 1.69 |
| Quick Ratio | 1.49 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | 2.37 |
| Debt / FCF | 3.30 |
| Interest Coverage | 4.05 |
Financial Efficiency
Return on equity (ROE) is 2.02% and return on invested capital (ROIC) is 2.28%.
| Return on Equity (ROE) | 2.02% |
| Return on Assets (ROA) | 1.69% |
| Return on Invested Capital (ROIC) | 2.28% |
| Return on Capital Employed (ROCE) | 3.04% |
| Weighted Average Cost of Capital (WACC) | 5.66% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.35 |
| Inventory Turnover | 14.13 |
Taxes
In the past 12 months, KLSE:TMCLIFE has paid 8.36 million in taxes.
| Income Tax | 8.36M |
| Effective Tax Rate | 32.47% |
Stock Price Statistics
The stock price has increased by +1.14% in the last 52 weeks. The beta is 0.33, so KLSE:TMCLIFE's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | +1.14% |
| 50-Day Moving Average | 0.46 |
| 200-Day Moving Average | 0.47 |
| Relative Strength Index (RSI) | 37.22 |
| Average Volume (20 Days) | 206,490 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KLSE:TMCLIFE had revenue of MYR 393.03 million and earned 17.38 million in profits. Earnings per share was 0.01.
| Revenue | 393.03M |
| Gross Profit | 135.42M |
| Operating Income | 30.36M |
| Pretax Income | 25.74M |
| Net Income | 17.38M |
| EBITDA | 58.47M |
| EBIT | 30.36M |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
The company has 115.06 million in cash and 145.22 million in debt, with a net cash position of -30.15 million or -0.02 per share.
| Cash & Cash Equivalents | 115.06M |
| Total Debt | 145.22M |
| Net Cash | -30.15M |
| Net Cash Per Share | -0.02 |
| Equity (Book Value) | 867.18M |
| Book Value Per Share | 0.50 |
| Working Capital | 80.36M |
Cash Flow
In the last 12 months, operating cash flow was 57.69 million and capital expenditures -13.73 million, giving a free cash flow of 43.96 million.
| Operating Cash Flow | 57.69M |
| Capital Expenditures | -13.73M |
| Depreciation & Amortization | 28.11M |
| Net Borrowing | -40.51M |
| Free Cash Flow | 43.96M |
| FCF Per Share | 0.03 |
Margins
Gross margin is 34.46%, with operating and profit margins of 7.72% and 4.42%.
| Gross Margin | 34.46% |
| Operating Margin | 7.72% |
| Pretax Margin | 6.55% |
| Profit Margin | 4.42% |
| EBITDA Margin | 14.88% |
| EBIT Margin | 7.72% |
| FCF Margin | 11.18% |
Dividends & Yields
This stock pays an annual dividend of 0.01, which amounts to a dividend yield of 1.25%.
| Dividend Per Share | 0.01 |
| Dividend Yield | 1.25% |
| Dividend Growth (YoY) | 209.68% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 18.67% |
| Buyback Yield | n/a |
| Shareholder Yield | 1.25% |
| Earnings Yield | 2.24% |
| FCF Yield | 5.67% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KLSE:TMCLIFE has an Altman Z-Score of 2.75 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.75 |
| Piotroski F-Score | 7 |